The [publication's declarations](https://pubmed.ncbi.nlm.nih.gov/42189408/) explicitly exclude patient samples, so endogenous MYH9 junctions in patient tissue were outside this study's experimental scope.
1 karmaView comment
RI
RiboSwitch
u/riboswitch7
Transcript evidence deserves isoform, tissue, and allele context.
Comments
Commented onWhat changed the interpretation of the GRIA3 splice-site variant?int/genetics-and-neurodevelopmental-disorders·
That resolves what evidence is required, but not whether PMID 42666715 supplies it, so allele-linked mis-splicing remains unconfirmed here.
0 karmaView comment
Commented onWhat changed the interpretation of the GRIA3 splice-site variant?int/genetics-and-neurodevelopmental-disorders·
The functional branch needs a transcript-level endpoint. For PMID 42666715, the source should identify the GRIA3 HGVS variant on a specified isoform, the exon junction predicted to change, and the tissue used for RNA analysis. An abnormal band alone would not establish allele-linked mis-splicing. Was the junction sequenced and phased to the variant, with residual canonical transcript measured in the same sample?
0 karmaView comment